arrow
A

Axel Bex

Netherlands Cancer Institute
H指数:66
被引数:2.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

71 Integrated Spatial Multi-omics Reveals Tumour Immune Microenvironment Programmes Underlying Durable Response and Resistance to Dual ICI Therapy in ccRCC

71 整合空间多组学揭示ccRCC中持久应答和抗双ICI疗法下的肿瘤免疫微环境调控程序

2026-09-020
OAAI
2 Relationships Between Plasma KIM-1 Levels, Peripheral Immune Profiles and Disease-Free Survival Outcomes in the TransRAMPART Study

2 血浆KIM-1水平、外周免疫谱与无病生存结局之间的关系:TransRAMPART研究

2026-09-020
OAAI
Salvage therapies for local recurrence of renal cell carcinoma: a systematic review and meta-analysis

肾细胞癌局部复发的挽救性治疗方法:一项系统评价和荟萃分析

2026-08-160
OA
Nephron Sparing Treatment (NEST) for small renal masses: understanding patients' and clinicians' experiences of a cohort-embedded randomised control trial

肾单位保留治疗(NEST)在小型肾肿瘤中的应用:理解队列嵌入型随机对照试验中患者与临床医生的经验

2026-05-130
PRE
Long-term Real-world Survival Outcomes with Dual Immune Checkpoint Blockade in Synchronous Metastatic Renal Cell Carcinoma: Implications for the Design of Prospective Cytoreductive Nephrectomy Trials

同步转移性肾细胞癌中双免疫检查点抑制剂的长期真实世界生存结局:对前瞻性细胞减灭性肾切除术试验设计的启示

2025-12-190
OAAI
Peritoneal recurrence following nephrectomy for localized renal cancer: A multicenter European real-world analysis of incidence, pattern and treatment (PEMET study-UroCCR 124)

局限性肾癌根治性肾切除术后的腹膜复发:一项多中心欧洲真实世界分析腹膜复发的发生率、模式及治疗(PEMET研究-UroCCR 124)

2025-12-010
PRE
International neoadjuvant kidney cancer consortium guidelines on assessing pathological response after neoadjuvant therapy in kidney cancer

国际肾癌新辅助治疗联合研究组关于评估肾癌新辅助治疗后病理反应的指南

2025-10-010
OAAI
Exploring Health-Related quality of life across the disease spectrum in renal cell carcinoma: a conceptual domain analysis

探索肾细胞癌疾病谱中健康相关生命质量的领域分析

2025-10-010
OA
Assessing pathological response to neoadjuvant therapy in renal cell carcinoma: a systematic review and guidelines for sampling and reporting standards from the International Neoadjuvant Kidney Cancer Consortium

评估肾细胞癌新辅助治疗的病理反应:国际新辅助肾癌联盟关于采样和报告标准的系统评价及指南

2025-09-290
PRE
[99mTc]Tc-sestamibi SPECT/CT for the diagnosis of kidney tumours: a multi-centre feasibility study (MULTI-MIBI Study)

[99mTc]Tc-sestamibi SPECT/CT在肾脏肿瘤诊断中的应用:一项多中心可行性研究(MULTI-MIBI研究)

2025-09-230
OAAI
Urine Glycosaminoglycan Scores for Surveillance of Recurrence in Intermediate- and High-risk Nonmetastatic Clear Cell Renal Cell Carcinoma—An Observational Prospective Multicentre Diagnostic Test Cohort Study

尿糖胺聚糖评分用于监测中高危非转移性透明细胞肾细胞癌复发—一项前瞻性多中心诊断试验队列研究

2025-08-270
OAAI